首页> 美国卫生研究院文献>Journal of Clinical Laboratory Analysis >Reference distributions for complement proteins C3 and C4: A practical simple and clinically relevant approach in a large cohort
【2h】

Reference distributions for complement proteins C3 and C4: A practical simple and clinically relevant approach in a large cohort

机译:补体蛋白C3和C4的参考分布:大型人群中实用简单且临床相关的方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The two serum proteins of the complement cascade in the highest concentrations, C3 and C4, respond to various conditions in much the same manner as do other positive acute‐phase proteins. A major difference is that they are relatively sluggish in response to cytokine drive, requiring several days rather than hours to be detectably elevated by serial measurements. As with other acute‐phase proteins, there are many processes that up‐ or down‐regulate synthesis, including infection or inflammation, hepatic failure, and immune‐complex formation. Clinicians may find it difficult to distinguish among these processes, because they often occur simultaneously. The situation is further complicated by genetic polymorphism, with rare instances of markedly reduced synthesis and circulating levels, and consequent vulnerability to infection. C3 and C4 are measured for clinical purposes to help define certain rheumatic and immunologically mediated renal diseases. Interpreting the measured blood levels of these two components requires one to consider the intensity of the inflammatory drive, the timing of the suspected clinical process, the production of complement‐consuming immune complexes, and the possible existence of benign circumstances. In this fifth article in a series, reference ranges for serum levels of two complement proteins (C3 and C4) are examined. The study is based on a cohort of over 55,000 Caucasian individuals from northern New England, who were tested in our laboratory in 1994–1999. Measurements were standardized against certified reference material (CRM) 470/reference preparation for proteins in human serum (RPPHS), and analyzed using a previously described statistical approach. Individuals with unequivocal laboratory evidence of inflammation (C‐reactive protein of 10 mg/L or higher) were excluded. Our results show that the levels of C3 and C4 change little during life and between the sexes, except that they increase slightly and then fall after age 20 in males and at about age 45 in females. When values were expressed as multiples of the age‐ and gender‐specific median levels, the resulting distributions fitted a log‐Gaussian distribution well over a broad range. When patient data are normalized in this manner, the distribution parameters can be used to assign a centile corresponding to an individual's measurement, thus simplifying interpretation. J. Clin. Lab. Anal. 18:1–8, 2004. © 2004 Wiley‐Liss, Inc.
机译:补体中的两种血清蛋白C3和C4的浓度最高,对其他条件的响应方式与其他阳性急性期蛋白基本相同。一个主要的区别是它们对细胞因子驱动的反应相对较慢,需要数天而不是数小时才能通过串行测量被检测到升高。与其他急性期蛋白一样,有许多过程会上调或下调合成,包括感染或炎症,肝功能衰竭和免疫复合物形成。临床医生可能会发现很难区分这些过程,因为它们经常同时发生。遗传多态性使情况进一步复杂化,罕见情况下合成和循环水平显着降低,因此容易感染。测量C3和C4是出于临床目的,以帮助定义某些风湿病和免疫介导的肾脏疾病。解释这两个成分的测得血液水平,需要考虑炎症驱动的强度,疑似临床过程的时机,消耗补体的免疫复合物的产生以及良性情况的可能存在。在本系列的第五篇文章中,检查了两种补体蛋白(C3和C4)的血清水平参考范围。这项研究是基于1994-1999年在我们实验室进行的新英格兰北部超过55,000名高加索人的队列研究。根据认证的参考物质(CRM)470 /人血清中蛋白质的参考制剂(RPPHS)对测量进行标准化,并使用先前描述的统计方法进行分析。明确无炎症实验室证据(C反应蛋白为10 mg / L或更高)的个体被排除在外。我们的结果表明,C3和C4的水平在生活中和两性之间变化不大,只是男性略有增加,然后在20岁以后下降,而女性在45岁左右下降。当将值表示为特定于年龄和性别的中位数水平的倍数时,所得分布在很宽的范围内均符合对数-高斯分布。以这种方式对患者数据进行归一化后,可以使用分布参数来分配与个人测量值相对应的百分位数,从而简化解释。 J.临床实验室肛门2004年18:1-8。©2004 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号